期刊文献+

应用光学相干断层成像评价药物洗脱支架术后再发急性冠脉综合征患者的原因 被引量:4

Pathology analysis of the recurrence ACS patients who had implanted DES by use of optical coherence tomography
原文传递
导出
摘要 目的探讨冠脉药物洗脱支架术后再发急性冠脉综合征(ACS)患者的可能原因。方法收集自2010年8月至2012年7月,本中心收治11例曾接受过冠脉支架介入治疗(PCI)治疗并植入药物涂层支架(DES),再发ACS的(男性9例,女性2例)患者,对该11例患者进行回顾性分析。应用光学相干断层显像(OCT)技术对罪犯血管检查,了解罪犯血管的病变情况。结果 DES植入术后再发ACS者不稳定性心绞痛(UA)多见,7例(7/11,63.6%),非ST段抬高心肌梗死(NSTEMI)1例(1/11,9%),ST段抬高心肌梗死(STEMI)3例(3/11,27.2%)。罪犯血管前降支(LAD)多见,8例(8/11,72.7%),右冠脉(RCA)3例(3/11,27.2%)。STEMI患者冠脉造影(CAG)诊断为支架内血栓形成(ST),OCT诊断为支架贴壁不良,同时存在支架内新生粥样硬化斑块(NAP)形成并破裂,NSTEMI患者CAG诊断为晚期支架内血栓形成(LST),OCT诊断为支架内NAP形成并破裂。UA患者CAG诊断为LST,OCT诊断为NAP、支架贴壁不良。7例(63.6%)患者存在吸烟史〔7例(100%)未能戒烟〕,8例(72.7%)患者LDL-C控制不达标。结论支架贴壁不良和支架内新生粥样硬化斑块破裂均可导致LST的发生。支架内新生动脉粥样硬化斑块是引起DES植入后再发ACS的另一主要病因。 Objective To analyze the pathology of the recurrence ACS patients who had implanted DES. Methods Data of llpatients who had underwent PCI were ACS reoccur from August 2010 to July 2012 were analyzed. Results The most patients were unstable angina(7/l1,63. 6% ) , one case for NSTEMI (1/11,9%) ,three cases for STEMI(3/ll, 27.2% ). In the culprit vessel, LAD accouted for (8/11,72.7%). The RCA was (3/11,27.2%). The pathology of STEMI and NSTEMI from CAG was late thrombosis, but from OCT was stent struts malapposition and nouveau atheroscl erotic plaque respectively. The pathology of UA from CAG was restenosis, from OCT was nouveau atherosclerotic plaque. 7 patients were smokers. Eight of 11 patients whose level of LDL - C was higher. Conclusion Nouveau ather- osclerotic plaques within the stented segment is another cause in the recurrence of acute coronary syndrome patients who had implanted DES. Stent struts malapposition and Nouveau atherosclerotic plaques within the stented segment are the substrate for the late thrombosis after DES placement.
出处 《医药论坛杂志》 2013年第8期13-15,18,共4页 Journal of Medical Forum
关键词 急性冠状动脉综合征 经皮冠状动脉介入治疗 光学相干断层显像 Acute coronary syndrome Percutaneous coronary intervention Optical coherence tomography
  • 相关文献

参考文献9

  • 1Kubo T, Akasaka T. Optical coherence tomography imaging: current status and future perspectives current and future developments in OCT[J]. Cardiovas Interve anTherape ,2010,25 ( 1 ) :2-10.
  • 2Kubo T,Imanishi Z,Takarada S,et al. Assessment of culprit lesion morphology in acute myocardial infarction ability of optical coher- ence tomography compared with intravascular ultrasound and coro- nary angioscopy [J ]. J Am Coil Cardio1,2007 riO(10) :933-939.
  • 3Diaz - Sandoval LJ, Bouma BE, Teamey G J, et al. Optical coher- ence tomography as a tool for percutaneous coronary interventions [ J]. Catheter Cardiovasc lnterv,2005,65 (4) :492-496.
  • 4Cualip DE,Windecker S, Mehran R,et al. Clinical end points in coronary stent trials:a case for standardizeddefinitions [J ]. Circu- lation,2007,115 ( 17 ) :2344-2351.
  • 5Yabushita H, Bouma BE, Houser SL, et al. Charact,rization ofhuman atherosclerosis by optical coherencetomography [J ]. Cir- culation ,2002,106 ( 13 ) : 1640-1645.
  • 6Cook S, Wenaweser P, et al. Incomplete stent apposition and very late stent thrombosis after drug - eluting stent implantation [ J ]. Circulation,2007,115 ( 18 ) :2426-2434.
  • 7Gonzalo N, Barlis P, et al. Incomplete stent apposition and de- layed tissue coverage are more frequent in drug - eluting stents implanted during primary percutaneous coronary intervention for ST - elevation myocardial infarction than in drug - eluting stents implanted for stable/unstable angina:insights from optical coher- ence tomography [J ]. JACC Cardiovasc Interv, 2009,2 ( 5 ) : 445- 452.
  • 8Yamaji K, Inoue K, Nakahashi T, et al. Bare metal stent thrombo- sis and in - sent neoatheroselerosis [ J ]. Cire Cardiovase Interv, 2012,5 ( 1 ) :47-54.
  • 9Nakazawa G, Otsuka F, Nakano M, et al. The pathology of neoth- ersclerosis in human coronary implants bare - metal and drug - eluting stents[ J]. J Am Coll Cardio1,2011,57 ( 11 ) : 1314-1322.

同被引文献54

  • 1杜润,张瑞岩.晚期支架贴壁不良研究进展[J].国际心血管病杂志,2008,35(6):353-356. 被引量:4
  • 2李松,张敏州,邹旭,陈伯钧,严厦,李健,王侠,林晓忠,邓铁涛.辨证分型治疗对冠心病介入术后患者血浆FIB及血脂的影响[J].南京中医药大学学报,2005,21(2):89-92. 被引量:25
  • 3CHEN Ke-ji,SHI Da-zhuo,XU Hao,LUE Shu-zheng,LI Tian-chang,KE Yuan-nan,ZHANG Min-zhou,LU Xiao-yan,SUN Rui-yuan,YOU Shi-jie.XS0601 REDUCES THE INCIDENCE OF RESTENOSIS: A PROSPECTIVE STUDY OF 335 PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN CHINA[J].Chinese Medical Journal,2006(1):6-13. 被引量:87
  • 4Nobuyoshi TK, Nosaka SM. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coil Cardiol, 1988, 12: 616-623.
  • 5Mohan S, Dhall A. A comparative study of restenosis rates in bare metal and drug-eluting stents. Int J Angiol, 2010, 19: e66-72.
  • 6Park SJ, Kang SJ, Virmani R, et al. In-stent neoatherosclerosis: a final common pathway of late stent failure. J Am Coll Cardiol, 2012, 59: 2051-2057.
  • 7Wong DT, Soh SY, Malaiapan Y. In-stent thrombosis due to neoatherosclerosis: insight from optical coherence tomography. J lnvasive Cardiol, 2013, 25: 304.
  • 8Otsuka F, Vorpahl M, Nakano M, et al. Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and Paclitaxel-eluting stents in humans. Circulation, 2014, 129:211-223.
  • 9Tian F, Chen Y, Liu H, et al. Assessment of Characteristics of Neointimal Hyperplasia after Drug-Eluting Stent Implantation in Patients with Diabetes Mellitus: An Optical Coherence Tomography Analysis. Cardiology, 2014, 128: 34-40.
  • 10Nakazawa G, Vorpahl M, Finn AV, et al. One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis. JACC Cardiovasc Imaging, 2009, 2: 625-628.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部